IQVIA™ Pharma Deals: PharmaDeals Review: Table of Contents

<< Previous Issue

Jul 2026 (Vol: 2026, Issue: 7)

Next Issue >>

Section: Licensing
AstraZeneca Signs US$2.1 B Respiratory Disease Licensing Agreement with Sino Biopharmaceutical for TQC3721 Published: 28 Jul-2026
By: Nikita Negi
Abstract Fulltext:
Section: Mergers & Acquisitions
GSK Expands Oncology Portfolio with US$10.6 B Acquisition of Nuvalent Published: 16 Jul-2026
By: Sanya Sekhri
Abstract Fulltext:
AbbVie Deepens Immunology Leadership with US$10.9 B Acquisition of Apogee Therapeutics Published: 16 Jul-2026
By: Nikita Negi
Abstract Fulltext:
Ipsen Expands Rare Disease Portfolio with US$1 B+ Acquisition of Memo Therapeutics Published: 16 Jul-2026
By: Naini Anand
Abstract Fulltext:
Vertex to Acquire Crinetics Pharmaceuticals for US$10 B Published: 25 Jul-2026
By: Ayush Saxena
Abstract Fulltext:
Lilly to Acquire AtaiBeckley to Advance Therapies Targeting Resistant Depression and Other Mental Health Conditions for US$3.8 B Published: 29 Jul-2026
By: Naini Anand
Abstract Fulltext:
Section: Research & Development
AstraZeneca Signs US$1.77 B Renal Disease Licensing Pact with CSPC Pharmaceutical Group Published: 20 Jul-2026
By: Nikita Negi
Abstract Fulltext:

PharmaDeals has now moved to a new platform (https://analyticslink.customerportal.iqvia.com). The current PharmaDeals website will be disabled from October 31, 2026. Please update your bookmarks and, if you have any issues accessing the new platform, please contact your IQVIA account manager.

Login

Username:

Password:

Keep me logged in